STLN
The Oncology Institute, Inc.
6.60$
+7.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 65.1% | 65.6% | 67.3% | 68.5% | 69.5% | 72.4% | |
| 24.2% | 19.0% | 16.9% | 20.4% | 18.0% | 23.1% | |
| – | – | 16.9% | 20.4% | 18.0% | 23.1% | |
| 30.1% | 34.8% | 36.7% | 36.0% | 35.3% | 37.4% | |
| 7.5% | 9.9% | 11.5% | 10.2% | 14.4% | 11.2% | |
| 4.4% | 4.5% | 4.4% | 4.4% | 4.3% | 4.1% | |
| 8.6% | 7.8% | 7.2% | 6.7% | 6.1% | 5.4% | |
| 96.9% | 105.6% | 107.5% | 109.5% | 109.7% | 114.0% | |
| 36.3% | 40.5% | 40.1% | 43.1% | 47.2% | 53.3% | |
| – | – | 4.4% | 4.3% | 4.4% | 4.1% | |
| 17.9% | 21.9% | 21.8% | 26.2% | 28.3% | 33.8% | |
| 45.1% | 46.9% | 46.6% | 47.0% | 46.7% | 44.8% | |
| 3.1% | -5.6% | -7.5% | -9.5% | -9.7% | -14.0% | |
| -140.5% | -154.8% | -161.3% | -164.8% | -162.8% | -159.2% | |
| 54.2% | 58.4% | 59.6% | 61.6% | 60.5% | 57.8% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.